These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1113 related articles for article (PubMed ID: 32010188)
1. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma. Li W; Lu J; Ma Z; Zhao J; Liu J Front Genet; 2019; 10():1323. PubMed ID: 32010188 [No Abstract] [Full Text] [Related]
2. Novel Molecular Subtyping Scheme Based on In Silico Analysis of Cuproptosis Regulator Gene Patterns Optimizes Survival Prediction and Treatment of Hepatocellular Carcinoma. Jiang H; Chen H; Wang Y; Qian Y J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762710 [TBL] [Abstract][Full Text] [Related]
3. A Nomogram Based on a Three-Gene Signature Derived from AATF Coexpressed Genes Predicts Overall Survival of Hepatocellular Carcinoma Patients. Liu J; Lu J; Ma Z; Li W Biomed Res Int; 2020; 2020():7310768. PubMed ID: 32382568 [TBL] [Abstract][Full Text] [Related]
4. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
5. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Liu GM; Zeng HD; Zhang CY; Xu JW Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015 [TBL] [Abstract][Full Text] [Related]
6. Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma. Wang X; Qiao J; Wang R Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111935 [TBL] [Abstract][Full Text] [Related]
7. Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis. Wang D; Liu J; Liu S; Li W Front Genet; 2020; 11():342. PubMed ID: 32391055 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. Yan Z; He M; He L; Wei L; Zhang Y Front Immunol; 2021; 12():723271. PubMed ID: 34925311 [TBL] [Abstract][Full Text] [Related]
10. A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma. Liang XY; Zhang Y; He YN; Liu XY; Ding ZH; Zhang XD; Dong MY; Du RL Front Genet; 2022; 13():888601. PubMed ID: 36171884 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma. Li X; Lin J; Pan Y; Cui P; Xia J Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477 [No Abstract] [Full Text] [Related]
12. Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification. Chen Z; Du D; Li J; Zhang W; Shao J Transl Cancer Res; 2024 Mar; 13(3):1268-1289. PubMed ID: 38617510 [TBL] [Abstract][Full Text] [Related]
13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
14. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation. Guan R; Zou J; Mei J; Deng M; Guo R BMC Cancer; 2022 Jul; 22(1):830. PubMed ID: 35907846 [TBL] [Abstract][Full Text] [Related]
15. Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma. Nie G; Zhu X; Zhang H; Wang H; Yan J; Li X Cancer Rep (Hoboken); 2024 Apr; 7(4):e1978. PubMed ID: 38599581 [TBL] [Abstract][Full Text] [Related]
16. A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma. Huang Y; Chen S; Qin W; Wang Y; Li L; Li Q; Yuan X Front Oncol; 2020; 10():580513. PubMed ID: 33251144 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
18. Exploration and validation of the prognostic value of RNA-binding proteins in hepatocellular carcinoma. Wang J; Han K; Li Y; Zhang C; Cui WH; Zhu LH; Luo T; Bian CJ Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8945-8958. PubMed ID: 36524514 [TBL] [Abstract][Full Text] [Related]
19. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma. Lin Z; Xu Q; Song X; Zeng Y; Zeng L; Zhao L; Xu J; Miao D; Chen Z; Yu F Front Oncol; 2022; 12():748557. PubMed ID: 35311113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]